封面
市場調查報告書
商品編碼
1449603

全球葡萄糖生物感測器市場:按技術、按應用、按最終用途、按地區

Global Glucose Biosensor Market, By Technology, By Application, By End Use, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球葡萄糖生物感測器市場規模預計將從2023年的117.7億美元增加到2031年的213億美元,預測期間(2024-2031年)的年複合成長率(CAGR)為7.7%。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 117.7億美元
實際資料 2019-2023 預測期 2024-2031
預測期間2023/2024 至2030/2031年年複合成長率: 7.70% 2030/2031價值預測 213億美元
圖 1.2024年葡萄糖生物感測器的全球市場佔有率(%)(依地區)
全球葡萄糖生物感測器市場-IMG1

預計全球葡萄糖生物感測器市場在預測期內將顯著成長。葡萄糖生物感測器是一種用於檢測生物樣本中葡萄糖濃度的分析裝置。它結合了生物辨識元件,例如葡萄糖氧化酵素酶和葡萄糖結合蛋白質。生物辨識元件固定在物理化學感測器上,並將生物事件轉換為可量化的分析訊號。糖尿病盛行率的增加以及有關自我監測和居家照護的嚴格監管通訊協定是推動該市場成長的主要因素。微創、低成本、高精度和方便用戶使用的生物感測器開發方面的技術進步加速其在照護現場和家庭應用中的採用。

市場動態:

全球葡萄糖生物感測器市場的成長是由老年人口的增加和全球糖尿病盛行率的增加所推動的。根據國際糖尿病聯盟的資料,2019年約有 4.63 億成年人(20 至 79 歲)患有糖尿病,預計到2045年將增加至 7 億。這導致自我監測血糖的需求顯著增加。此外,有利的償付政策和政府促進血糖自我監測的措施推動市場成長。然而,嚴格的監管核准和與生物感測器相關的高成本預計將在預測期內在一定程度上阻礙市場擴張。從積極的一面來看,穿戴式、非侵入式、智慧型手機整合生物感測器的研發取得進展,開闢了新的途徑。

本研究的主要特點

  • 本報告對全球葡萄糖生物感測器市場進行了詳細分析,並提供了以2023年為基準年的預測期(2024-2031)的市場規模和年複合成長率(CAGR%)。
  • 它闡明了各個細分市場的潛在收益成長機會,並解釋了該市場有吸引力的投資提案矩陣。
  • 提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 根據公司亮點、產品系列、主要亮點,實績和策略等參數,介紹了全球葡萄糖生物感測器市場的主要企業。
  • 本報告的見解將使行銷人員和經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略負責人明智的決策。
  • 全球葡萄糖生物感測器市場報告針對該行業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球葡萄糖生物感測器市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 糖尿病盛行率上升
    • 老年人口增加
    • 嚴格的監理政策
  • 主要亮點
  • 監管場景
  • 最近的趨勢
  • PEST分析
  • 波特的分析
  • 產品發表會
  • 合併、收購和合作

第4章 全球葡萄糖生物感測器市場—冠狀病毒(COVID-19)大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章 全球葡萄糖生物感測器市場,依技術,2019-2031

  • 酵素生物感測器
  • 非酵素生物感測器

第6章 全球葡萄糖生物感測器市場,依應用分類,2019-2031

  • 家庭診斷
  • 醫院和診所
  • 研究與開發

第7章 全球葡萄糖生物感測器市場,依最終用戶分類,2019-2031年

  • 醫院
  • 居家護理
  • 診斷中心

第8章 全球葡萄糖生物感測器市場,依地區,2019-2031

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭格局

  • 公司簡介
    • Abbott Laboratories
    • Dexcom
    • Ascenia Diabetes Car Company Highlights
    • Nova Diabetes Care
    • F.Hoffmann-La Roche Ltd.
    • Sanofi
    • GlySens Incorporated
    • Trividia Health
    • Bayer
    • Lifescan

第10章

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6631

The global glucose biosensor market size is expected to reach US$ 21.3 Bn by 2031 from US$ 11.77 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 7.7% during the forecast period (2024-2031).

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 11.77 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 7.70% 2030/2031 Value Projection: US$ 21.3 Bn
Figure 1. Global Glucose Biosensor Market Share (%), By Region, 2024
Global Glucose Biosensor Market - IMG1

The global glucose biosensor market is poised to grow at a significant rate over the forecast period. A glucose biosensor is an analytical device used for the detection of glucose concentration in biological samples. It incorporates a bio-recognition element like glucose oxidase enzyme or glucose-binding protein. The bio-recognition element is immobilized on a physicochemical transducer that transforms the biological event into a quantifiable analytical signal. Increased prevalence of diabetes and stringent regulatory protocols related to self-monitoring and homecare are the key factors driving the growth of this market. Technological advancements in developing minimally invasive, low-cost, accurate, and user-friendly biosensor have accelerated their adoption in point-of-care and home-use applications.

Market Dynamics:

The growth of the global glucose biosensor market is driven by rising geriatric population and increasing incidence of diabetes across the world. As per the International Diabetes Federation, around 463 million adults (20-79 years) were living with diabetes in 2019 and the number is projected to increase to 700 million by 2045. This has significantly increased the demand for self-monitoring of blood glucose. Moreover, favorable reimbursement policies and government initiatives to promote self-monitoring are providing impetus to the market growth. However, stringent regulatory approvals and high costs associated with biosensor are expected to hinder the market expansion to some extent during the forecast period. On the positive side, ongoing R&D to develop wearable, non-invasive, and smartphone integrated biosensor opens new avenues.

Key Features of the Study:

  • This report provides an in-depth analysis of the global glucose biosensor market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global glucose biosensor market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbott Laboratories, Dexcom, Ascenia Diabetes Care, Nova Diabetes Care, F. Hoffmann-La Roche Ltd., Sanofi, GlySens Incorporated, Trividia Health, Bayer, and Lifescan.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global glucose biosensor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glucose biosensor market.

Detailed Segmentation:

  • Global Glucose Biosensor Market, By Technology
    • Enzymatic Biosensor
    • Non-Enzymatic Biosensor
  • Global Glucose Biosensor Market, By Application
    • Home Diagnostics
    • Hospitals and Clinics
    • Research and Development
  • Global Glucose Biosensor Market, By End Use
    • Hospitals
    • Homecare
    • Diagnostic centers
  • Global Glucose Biosensor Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top Companies in the Global Glucose Biosensor Market:
    • Abbott Laboratories
    • Dexcom
    • Ascenia Diabetes Care
    • Nova Diabetes Care
    • Hoffmann-La Roche Ltd.
    • Sanofi
    • GlySens Incorporated
    • Trividia Health
    • Bayer
    • Lifescan

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising prevalence of diabetes
    • Growing geriatric population
    • Stringent regulatory policies
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Product Launches
  • Mergers, Acquisitions, and Collaborations

4. Global Glucose Biosensor Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Glucose Biosensor Market, By Technology, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Enzymatic Biosensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Non-Enzymatic Biosensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Glucose Biosensor Market, By Application, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Home Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Glucose Biosensor Market, By End User, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Homecare
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Diagnostic centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Glucose Biosensor Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020 -2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profile
    • Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Dexcom
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Ascenia Diabetes Car Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Nova Diabetes Care
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • F.Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GlySens Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Trividia Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Bayer
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Lifescan
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us